These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26975597)

  • 41. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compounding facilities assessment and planning: A focus on USP <797> and USP <800>.
    Clark JS; Tharp JC; Patel D; Desmarais A
    Am J Health Syst Pharm; 2020 Oct; 77(22):1910-1913. PubMed ID: 32839816
    [No Abstract]   [Full Text] [Related]  

  • 43. [Standardization as a basis planning and administration in drug industry and pharmacy (II)].
    Wagler M
    Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874
    [No Abstract]   [Full Text] [Related]  

  • 44. [Development in drug control].
    Marini Bettolo GB
    Farmaco Prat; 1971 Jul; 26(7):367-82. PubMed ID: 5561802
    [No Abstract]   [Full Text] [Related]  

  • 45. Recommendations to eliminate subjective olfactory methods from compendial identification tests.
    Schwartzman G
    J Pharm Sci; 1978 Apr; 67(4):539-45. PubMed ID: 641764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sterilization of compounded parenteral preparations: verification of autoclaves.
    Rahe H
    Int J Pharm Compd; 2013; 17(2):94-8. PubMed ID: 23696169
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Assessment of the quality and certification of biologically active synthetic and natural compounds].
    Popkov VA; Reshetniak VIu; Dugacheva GM
    Vestn Ross Akad Med Nauk; 1995; (10):39-44. PubMed ID: 8601090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential impact of USP 797 and what the JCAAI is doing about it.
    Nathan R
    Allergy Asthma Proc; 2007; 28(2):236-7. PubMed ID: 17479611
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug standards in military procurement.
    Feinberg M
    J Am Pharm Assoc; 1969 Mar; 9(3):113-6 passim. PubMed ID: 5781991
    [No Abstract]   [Full Text] [Related]  

  • 50. New recommendations to modernize drug manufacturing.
    FDA Consum; 2007; 41(1):4. PubMed ID: 17354283
    [No Abstract]   [Full Text] [Related]  

  • 51. Revisions continue on USP sterile-compounding chapter.
    Thompson CA
    Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
    [No Abstract]   [Full Text] [Related]  

  • 52. Equivalence studies for complex active ingredients and dosage forms.
    Bhattycharyya L; Dabbah R; Hauck W; Sheinin E; Yeoman L; Williams R
    AAPS J; 2005 Nov; 7(4):E786-812. PubMed ID: 16594632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implementing United States Pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, Part 1.
    Allen LV
    Int J Pharm Compd; 2012; 16(2):146-9. PubMed ID: 23050327
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contemporary pharmaceutical compounding.
    Allen LV
    Ann Pharmacother; 2003 Oct; 37(10):1526-8. PubMed ID: 14519042
    [No Abstract]   [Full Text] [Related]  

  • 55. Implementing United States pharmacopeia chapter <1163> quality assurance in pharmaceutical compounding, part 2: documentation and verification.
    Allen LV
    Int J Pharm Compd; 2012; 16(3):230-4. PubMed ID: 23050301
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Biochemical bases of drug action. Introduction].
    Büchi J
    Pharm Acta Helv; 1968 Jun; 43(6):321-30. PubMed ID: 4880600
    [No Abstract]   [Full Text] [Related]  

  • 57. Probability lower bounds for USP/NF tests.
    Chow SC; Shao J; Wang H
    J Biopharm Stat; 2002 Feb; 12(1):79-92. PubMed ID: 12146721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perception of drug-name legibility by pharmacists and pharmacy technicians.
    Kennedy AG; Senders JW; Sellen K; Littenberg B; Callas PW; Carney JK
    Am J Health Syst Pharm; 2009 May; 66(9):794-5. PubMed ID: 19386937
    [No Abstract]   [Full Text] [Related]  

  • 59. The menace of substandard drugs.
    Roy J
    World Health Forum; 1994; 15(4):406-7. PubMed ID: 7999239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.